Farmantra, a Barcelona-based corporate finance advisory for life sciences companies specializing in early stage valuations, interim CFO support and fund raising, hosted a panel discussion on early stage value creation at Cal Tip Barcelona on the 29th of November. The discussion was focused on topics such as fund-raising management, early dilution through equity-raising, early licensing of assets, and so on.
SOM Biotech CEO Dr. Raúl Insa was invited to be one of the panelists to share his knowledge and experience on capital efficiency and early-stage asset valuation. Joined him were Guillem Laporta, Principal at Ysios Capital, Spain; Esteban Pombo-Villar, CEO of Targimmune, Switzerland; and Christofer Adding, COO of Attgeno, Sweden. The panel discussion was moderated by Farmantra Managing Partner & SOM Biotech CFO Saurabh Mishra.
Dr. Raúl Insa (SOM Biotech CEO)
Saurabh Mishra (SOM Biotech CFO)